← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 31, 2008Last known activity
May 17, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT04252131Reponsible party - principal investigatorPhase 1May 17, 2018
- NCT04252131Overall official - principal investigatorPhase 1May 17, 2018
- NCT04252131Lead sponsorPhase 1May 17, 2018
- NCT04754750Reponsible party - principal investigatorPhase 1/Phase 2Jan 31, 2015
- NCT04754750Overall official - principal investigatorPhase 1/Phase 2Jan 31, 2015
- NCT04754750Lead sponsorPhase 1/Phase 2Jan 31, 2015
- NCT03663465Lead sponsorN/AJan 1, 2013
- NCT03663465Reponsible party - principal investigatorN/AJan 1, 2013
- NCT03730857Overall official - principal investigatorPhase 1Jan 31, 2008
- NCT03730857Reponsible party - principal investigatorPhase 1Jan 31, 2008
- NCT03730857Lead sponsorPhase 1Jan 31, 2008
Details
- Last known activity
- May 17, 2018